Dr Waks on Later-Line Treatment Options in HER2+ Breast Cancer

Adrienne G. Waks, MD, discusses treatment alternatives in the third line and beyond for patients with metastatic HER2-positive breast cancer.

Related Keywords

Adrienneg Waks , ,Dana Farber Cancer Institute ,Harvard Medical School ,Clinical Research ,Onclive Tv ,Dana Farber Cancer Center ,Her2 Positive Breast Cancer ,Breast Cancer ,